| AKI event during follow-up | No AKI event during follow-up |
---|---|---|
(n = 4944) | (n = 20,204) | |
Age (Years) a | 71.7 (64.7 – 78.3) | 63.4 (54.2 – 72.1) |
Male Sex (%) | 2694 (54.5) | 11,031 (54.6) |
HbA1c % | 7.2 (6.4- 8.3) | 7.0 (7.4- 8.4) |
(mmol/mol) a | 55 (46 – 67) | 53 (45 - 68) |
Diabetes Duration (years) a | 0 (0 – 3) | 3.3 (0 – 9) |
Number of diabetes drug classes (%) | ||
0 | 2583 (52) | 14,212 (70) |
1 | 1617 (33) | 4471 (22) |
2 | 706 (14) | 1438 (7) |
3 | 27 (0.5) | 76 (0.4) |
4 | 1 | 6 |
5 | 0 | 1 |
ACE/ARB use (%) | 1505 (30) | 4667 (23) |
NSAID use (%) | 474 (10) | 2079 (10) |